News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
199,846 Results
Type
Article (31194)
Company Profile (37)
Press Release (168615)
Multimedia
Podcasts (128)
Webinars (10)
Section
Business (52190)
Career Advice (1811)
Deals (10330)
Drug Delivery (127)
Drug Development (31172)
Employer Resources (195)
FDA (6647)
Job Trends (5921)
News (100052)
Policy (12773)
Tag
2024 BioForest Standard (1)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (2)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (6)
2024 Biotech Beach Digital (1)
2024 Biotech Beach Standard (1)
2024 Genetown Standard (3)
2024 Pharm Country Standard (3)
2026 Bio NC Standard (1)
2026 Genetown Elite (1)
2026 Genetown Standard (1)
2026 Pharm Country Standard (1)
Academia (1631)
Accelerated approval (5)
Adcomms (29)
Allergies (37)
Alliances (14197)
ALS (40)
Alzheimer's disease (805)
Antibody-drug conjugate (ADC) (110)
Approvals (6533)
Artificial intelligence (130)
Autoimmune disease (17)
Automation (6)
Bankruptcy (122)
Best Places to Work (4608)
BIOSECURE Act (21)
Biosimilars (93)
Biotechnology (32)
Bladder cancer (32)
Brain cancer (18)
Breast cancer (134)
Cancer (998)
Cardiovascular disease (129)
Career advice (1521)
Career pathing (34)
CAR-T (98)
Cell therapy (222)
Cervical cancer (7)
Clinical research (24113)
Collaboration (337)
Compensation (65)
Complete response letters (24)
COVID-19 (2262)
CRISPR (20)
C-suite (80)
Cystic fibrosis (56)
Data (771)
Decentralized trials (2)
Denatured (45)
Depression (34)
Diabetes (148)
Diagnostics (2215)
Digital health (9)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (63)
Drug pricing (122)
Drug shortages (31)
Duchenne muscular dystrophy (56)
Earnings (17624)
Editorial (43)
Employer branding (25)
Employer resources (164)
Events (24216)
Executive appointments (212)
FDA (7045)
Featured Employer (16)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (5)
Funding (279)
Gene editing (53)
Generative AI (18)
Gene therapy (213)
GLP-1 (710)
Government (3304)
Grass and pollen (3)
Guidances (26)
Healthcare (6663)
Huntington's disease (23)
IgA nephropathy (21)
Immunology and inflammation (114)
Indications (10)
Infectious disease (2357)
Inflammatory bowel disease (95)
Inflation Reduction Act (11)
Influenza (27)
Intellectual property (29)
Interviews (357)
IPO (4142)
IRA (51)
Job creations (1393)
Job search strategy (1232)
Kidney cancer (8)
Labor market (42)
Layoffs (508)
Leadership (22)
Legal (2509)
Liver cancer (37)
Lung cancer (150)
Lymphoma (76)
Machine learning (3)
Management (64)
Manufacturing (162)
MASH (46)
Medical device (4234)
Medtech (4235)
Mergers & acquisitions (6345)
Metabolic disorders (529)
Multiple sclerosis (47)
NASH (21)
Neurodegenerative disease (74)
Neuropsychiatric disorders (32)
Neuroscience (1116)
NextGen: Class of 2025 (2638)
Non-profit (2060)
Northern California (762)
Now hiring (40)
Obesity (341)
Opinion (238)
Ovarian cancer (25)
Pain (35)
Pancreatic cancer (35)
Parkinson's disease (67)
Partnered (12)
Patents (95)
Patient recruitment (15)
Peanut (18)
People (15497)
Pharmaceutical (7)
Pharmacy benefit managers (21)
Phase I (6767)
Phase II (10378)
Phase III (9789)
Pipeline (527)
Policy (165)
Postmarket research (992)
Preclinical (2548)
Press Release (15)
Prostate cancer (46)
Psychedelics (34)
Radiopharmaceuticals (77)
Rare diseases (260)
Real estate (1761)
Recruiting (73)
Regulatory (8263)
Reports (50)
Research institute (1278)
Resumes & cover letters (283)
Rett syndrome (3)
RNA editing (4)
RSV (39)
Schizophrenia (50)
Series A (65)
Series B (31)
Service/supplier (2)
Sickle cell disease (28)
Southern California (633)
Special edition (18)
Spinal muscular atrophy (85)
Sponsored (34)
Startups (1394)
Stomach cancer (14)
Supply chain (42)
Tariffs (39)
The Weekly (81)
United States (6314)
Vaccines (657)
Venture capitalists (40)
Weight loss (285)
Women's health (27)
Worklife (19)
Date
Today (63)
Last 7 days (280)
Last 30 days (861)
Last 365 days (11044)
2025 (3383)
2024 (11877)
2023 (13132)
2022 (19544)
2021 (19800)
2020 (18731)
2019 (16782)
2018 (13464)
2017 (9748)
2016 (9081)
2015 (10011)
2014 (6913)
2013 (5501)
2012 (5782)
2011 (6065)
2010 (5335)
Location
Africa (454)
Alabama (11)
Alaska (3)
Arizona (29)
Arkansas (4)
Asia (11500)
Australia (2121)
California (1706)
Canada (554)
China (156)
Colorado (79)
Connecticut (103)
Delaware (41)
Europe (30776)
Florida (257)
Georgia (59)
Idaho (17)
Illinois (171)
India (10)
Indiana (124)
Iowa (5)
Japan (75)
Kansas (33)
Kentucky (7)
Louisiana (7)
Maine (28)
Maryland (307)
Massachusetts (1183)
Michigan (26)
Minnesota (61)
Missouri (30)
Montana (15)
Nebraska (5)
Nevada (35)
New Hampshire (12)
New Jersey (534)
New Mexico (6)
New York (559)
North Carolina (224)
Northern California (762)
Ohio (75)
Oklahoma (1)
Oregon (16)
Pennsylvania (299)
Puerto Rico (1)
Rhode Island (8)
South America (523)
South Carolina (3)
South Dakota (1)
Southern California (633)
Tennessee (26)
Texas (232)
Utah (35)
Virginia (37)
Washington D.C. (30)
Washington State (152)
West Virginia (1)
Wisconsin (24)
199,846 Results for "gi dynamics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
GI Alliance and Iterative Health Partner to Advance GI Clinical Research in the Community
April 23, 2025
·
3 min read
Press Releases
GI Innovation-LaNova Medicines Signs MOU for GI-102 + ADC Pancreatic Cancer Combination Therapy
January 23, 2025
·
2 min read
Press Releases
Proof-of-Concept Data for Rare Disease Indications MVID and SBS-IF for Jaguar Health’s Crofelemer to be Presented at April 2025 ELITE PED-GI Congress
April 18, 2025
·
7 min read
Genetown
GI Dynamics Announces Company Rebrand as Morphic Medical® Reintroducing Flagship Product as RESET®
GI Dynamics, creator of the world’s first medical device designed to target the underlying cause of type 2 diabetes, is proud to announce its rebrand to Morphic Medical and the introduction of RESET, formally known as EndoBarrier®.
July 11, 2023
·
3 min read
Press Releases
Natera to Present New Data at the 2025 ASCO GI Symposium
January 21, 2025
·
8 min read
Cancer
BMS, Pfizer Challenge Colorectal Cancer Standard Care With ASCO GI Readouts
Bristol Myers Squibb’s Opdivo plus Yervoy, as well as Pfizer’s Braftovi, have each shown strong Phase III performances that could position them as new standards of care in certain subtypes of metastatic colorectal cancer.
January 27, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Bexion Pharmaceuticals, Inc. Announces Poster Presentation at ASCO GI 2025
January 9, 2025
·
2 min read
Press Releases
RenovoRx Highlights Promising Pharmacokinetic Data Abstract Presented at ASCO GI 2025
January 27, 2025
·
11 min read
Phase III
Merck’s Keytruda Combo Fails to Extend Survival in Phase III GI Cancer
The unsuccessful Phase III results are the latest to suggest that the blockbuster cancer drug is finally bumping up
against its limits
after racking up around 50 approvals since getting its first FDA nod in September 2014.
January 24, 2025
·
2 min read
·
Annalee Armstrong
Press Releases
Biomerica’s inFoods® IBS Clinical Trial Results Published and Featured in Gastroenterology, the Leading GI Medical Journal
February 20, 2025
·
8 min read
1 of 19,985
Next
